论文信息 - Iberdomide (CC-220) Monotherapy or in Combination with an Anti-CD20 Monoclonal Antibody As Effective Therapy in Patients with Relapsed/Refractory Lymphoma: Early Results from a Phase 1/2 Study - 字舞流文

Iberdomide (CC-220) Monotherapy or in Combination with an Anti-CD20 Monoclonal Antibody As Effective Therapy in Patients with Relapsed/Refractory Lymphoma: Early Results from a Phase 1/2 Study

I. Flinn | L. Arcaini | C. Visco | F. Morschhauser | C. Thieblemont | P. Corradini | G. Cartron | L. Roulin | G. Nowakowski | A. Tucci | T. Gastinne | M. Topp | K. Bouabdallah | S. Jauhari | A. Gkasiamis | P. Martin | J. Drew | Ju Li | V. Vučinić | Y. Cheng | J. Munoz | Parth Rao | M. Kaplan